-
www.uspreventiveservicestaskforce.org/Home/GetFile/1/16812/prostate-models-overdiagnosis/pdf
May 01, 2018 - because of the cancer
diagnosis and they may be burdened by the testing and interventions used to monitor
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/MjwZ4vRLZDVUSnfMA6SrDo
June 01, 2012 - Results of the analysis
of a measure developed to monitor adverse effects for this
trial (Consequences
-
hcup-us.ahrq.gov/datainnovations/clinicalcontentenhancementtoolkit/hi25.jsp
September 01, 2014 - Enhancing Hawaii Hospital Information Content: Data Acquisition.
An official website of the Department of Health & Human Services
Search All AHRQ Websites
Careers
Contact Us
Espanol
…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary32/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening-2013
May 08, 2012 - acute care, and obstetrics and gynecology sites. 39 Results of the analysis of a measure developed to monitor
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/healthy-lifestyle-and-physical-activity-for-cvd-prevention-adults-without-known-risk-factors-behavioral-counseling
July 26, 2022 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Evidence Summary
Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions
…
-
digital.ahrq.gov/sites/default/files/docs/AHRQ%20Transcript%208-27-10.pdf
June 16, 2021 - nurses or other staff in rehab centers that are administering medication, and all of the
parties who monitor
-
digital.ahrq.gov/sites/default/files/docs/citation/europe-e-prescribing-report.pdf
February 01, 2011 - generate alerts
• Medication management, enabling providers to prescribe, transmit,
dispense and monitor
-
www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/2024-medical-office-database-report-rev.pdf
January 01, 2024 - Surveys on Patient Safety Culture (SOPS) Medical Office Survey: 2024 User Database Report Part I
SURVEYS ON PATIENT
SAFETY CULTURE®
2024 MEDICAL OFFICE
USER DATABASE REPORT
Surveys on
Patient Safety
Culture®
e PATIENT
SAFETY
[This page intentionally left blank]
Surveys on Patient Safety Culture® (SOPS®) …
-
www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/2022-mosops-database-report-part-I.pdf
January 01, 2022 - Surveys on Patient Safety Culture (SOPS®) Medical Office Survey: 2022 User Database Report Part I
SURVEYS
ON PATIENT
SAFETY
CULTURE™
Surveys on
Patient Safety
Culture™
MEDICAL OFFICE SURVEY:
2022 USER DATABASE REPORT
PATIENT
SAFETY
[This page intentionally left blank]
Surveys on Patient Safety Culture…
-
cdsic.ahrq.gov/sites/default/files/2023-08/SMD%20Workflow%20Measurement%20Approaches%20Report_to%20AHRQ%208.9.23_508.pdf
January 01, 2023 - Scaling, Measurement, and Dissemination of CDS Workgroup: Approaches to Measuring Patient-Centered CDS Workflow and Lifeflow Impact
Scaling, Measurement, and
Dissemination of CDS
Workgroup: Approaches to
Measuring Patient-Centered CDS
Workflow and Lifeflow Impact
Agency for Healthcare Research…
-
hcup-us.ahrq.gov/reports/methods/2016-08.pdf
January 01, 2016 - HCUP Methods Series
kbr33831
Contact Information:
Healthcare Cost and Utilization Project (HCUP)
Agency for Healthcare Research and Quality
5600 Fishers Lane
Room 07W17B
Mail Stop 7W25B
Rockville, MD 20857
http://www.hcup-us.ahrq.gov
For Technical Assistance with HCUP Products:
Email: hcup@ahr…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2021qdr-appendixes.pdf
December 01, 2021 - 2021 National Healthcare Quality and Disparities Report Appendixes
2021 National Healthcare Quality and Disparities Report
Appendixes
Appendix A: Data Sources Used for 2021 NHQDR
Appendix B: Definitions and Abbreviations Used in 2021 NHQDR
Appendix C: Measures Used in the 2021 State Maps
U.S. DEPARTMENT OF
…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/y6xRBv7uSZY5bGCx7y48x7
May 01, 2009 - Folic Acid Supplementation for the Prevention of Neural Tube Defects: An Update of the Evidence
Folic Acid Supplementation for the Prevention of Neural Tube
Defects: An Update of the Evidence for the U.S. Preventive Services
Task Force
Tracy Wolff, MD, MPH; Catherine Takacs Witkop, MD, MPH; Therese Miller, DrPH; and …
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - LOINC: 4548-4 should be used for reporting HbA1c in the U.S.”8
• Suggestions for future implementers: Monitor
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2019%20CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
January 01, 2019 - LOINC: 4548-4 should be used for reporting HbA1c in the U.S.”8
• Suggestions for future implementers: Monitor
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - LOINC: 4548-4 should be used for reporting HbA1c in the U.S.”8
• Suggestions for future implementers: Monitor
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - LOINC: 4548-4 should be used for reporting HbA1c in the U.S.”8
• Suggestions for future implementers: Monitor
-
cds.ahrq.gov/sites/default/files/cds/artifact/1071/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - LOINC: 4548-4 should be used for reporting HbA1c in the U.S.”8
• Suggestions for future implementers: Monitor
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - LOINC: 4548-4 should be used for reporting HbA1c in the U.S.”8
• Suggestions for future implementers: Monitor
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017099-weiner-final-report-2010.pdf
January 01, 2010 - Crossing the Quality Assessment Chasm: Aligning Measured and True Quality of Care
Grant Final Report
Grant ID: 1R18HS017099-01
Crossing the Quality Assessment Chasm: Aligning
Measured and True Quality of Care
Inclusive dates: 09/30/07 - 09/29/10
Principal Investigator:
Mark G. Weiner…